Evaluating passive physiological data collection during Spravato treatment.
Todd M Solomon, Matus Hajduk, Martin Majernik, Jamileh Jemison, Alexander Deschamps, Jenna Scoggins, Adam Kolar, Miguel Amável Pinheiro, Peter Dubec, Ondrej Skala, Owen Muir, Amanda Tinkelman, Daniel R Karlin, Robert Barrow
Frontiers in digital health January 1, 2023 DOI: 10.3389/fdgth.2023.1281529 via PubMed
Summary
AI-generated from the abstractA proof-of-concept study tested the MindMed Session Monitoring System (MSMS), a continuous passive monitoring system designed for use during treatment sessions with consciousness-altering drugs. Participants completed 129 Spravato sessions with MSMS at an outpatient psychiatry clinic. Results indicated high rates of data quality and self-reported usability among both participants and healthcare providers. These findings suggest that such systems could assist with patient monitoring during consciousness-altering treatments, potentially reducing the burden on providers and improving accessibility.
Study at a glance
| Characteristics | Proof-of-concept study Peer reviewed |
|---|---|
| Population | Outpatients receiving Spravato treatment at a psychiatry clinic |
| Topics | Depression Esketamine |
| Keywords | Dissociative Hallucinogen Mental health |
| Citations | 1 |
| Key finding | The MindMed Session Monitoring System showed high data quality and usability during Spravato sessions, indicating potential for use in patient monitoring during consciousness-altering treatments. |
Abstract
Spravato and other drugs with consciousness-altering effects show significant promise for treating various mental health disorders. However, the effects of these treatments necessitate a substantial degree of patient monitoring which can be burdensome to healthcare providers and may make these treatments less accessible for prospective patients. Continuous passive monitoring via digital devices may be useful in reducing this burden. This proof-of-concept study tested the MindMed Session Monitoring System™ (MSMS™), a continuous passive monitoring system intended for use during treatment sessions involving pharmaceutical products with consciousness-altering effects. Participants completed 129 Spravato sessions with MSMS at an outpatient psychiatry clinic specializing in Spravato treatment. Results indicated high rates of data quality and self-reported usability among participants and health care providers (HCPs). These findings demonstrate the potential for systems such as MSMS to be used in consciousness-altering treatment sessions to assist with patient monitoring.